These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1074 related articles for article (PubMed ID: 10321021)

  • 1. Involvement of cGMP in cellular melatonin responses.
    Bubis M; Zisapel N
    Biol Cell; 1999 Jan; 91(1):45-9. PubMed ID: 10321021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin receptors in benign prostate epithelial cells: evidence for the involvement of cholera and pertussis toxins-sensitive G proteins in their signal transduction pathways.
    Gilad E; Pick E; Matzkin H; Zisapel N
    Prostate; 1998 Apr; 35(1):27-34. PubMed ID: 9537596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for NAD+ and cADP-ribose in melatonin signal transduction.
    Bubis M; Zisapel N
    Mol Cell Endocrinol; 1998 Feb; 137(1):59-67. PubMed ID: 9607729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desensitization of NO/cGMP signaling in smooth muscle: blood vessels versus airways.
    Mullershausen F; Lange A; Mergia E; Friebe A; Koesling D
    Mol Pharmacol; 2006 Jun; 69(6):1969-74. PubMed ID: 16510560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
    Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the cGMP pathway in mediating the insulin-inhibitory effect of melatonin in pancreatic beta-cells.
    Stumpf I; Mühlbauer E; Peschke E
    J Pineal Res; 2008 Oct; 45(3):318-27. PubMed ID: 18363673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic GMP systems in the retina.
    Ferrendelli JA; De Vries GW
    Fed Proc; 1983 Nov; 42(14):3103-6. PubMed ID: 6138283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitation and inhibition of G-protein regulated protein secretion by melatonin.
    Bubis M; Zisapel N
    Neurochem Int; 1995 Aug; 27(2):177-83. PubMed ID: 7580873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic GMP-linked pathway for renin secretion.
    Noble AR; Abu-Kishk RA; D'Aloia MA; Williams BC; Lush DJ
    Kidney Int; 1994 Dec; 46(6):1588-90. PubMed ID: 7700014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the cGMP signaling pathway by melatonin in pancreatic beta-cells.
    Stumpf I; Bazwinsky I; Peschke E
    J Pineal Res; 2009 Mar; 46(2):140-7. PubMed ID: 19175857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cGMP-binding, cGMP-specific phosphodiesterase (PDE5): intestinal cell expression, regulation and role in fluid secretion.
    Sopory S; Kaur T; Visweswariah SS
    Cell Signal; 2004 Jun; 16(6):681-92. PubMed ID: 15093609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic guanosine monophosphate analogs do not reverse bacterial toxin modulation of lactogen-stimulated NB2 cell mitogenesis.
    Larsen JL
    Endocr Res; 1992; 18(1):31-40. PubMed ID: 1315680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between cyclic guanosine monophosphate accumulation and relaxation of canine trachealis induced by nitrovasodilators.
    Zhou HL; Torphy TJ
    J Pharmacol Exp Ther; 1991 Sep; 258(3):972-8. PubMed ID: 1679854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of four cGMP analogues with different mechanisms of action on hormone release by porcine ovarian granulosa cells in vitro.
    Sirotkin AV; Makarevich AV; Genieser HG; Kotwica J; Hetényi L
    Exp Clin Endocrinol Diabetes; 2000; 108(3):214-9. PubMed ID: 10926319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional identification of phosphodiesterase activity in human trabecular meshwork cells.
    Zhou L; Thompson WJ; Potter DE
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):317-22. PubMed ID: 10977127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling.
    Mullershausen F; Friebe A; Feil R; Thompson WJ; Hofmann F; Koesling D
    J Cell Biol; 2003 Mar; 160(5):719-27. PubMed ID: 12604588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
    Murray F; MacLean MR; Pyne NJ
    Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin receptors in PC3 human prostate tumor cells.
    Gilad E; Laufer M; Matzkin H; Zisapel N
    J Pineal Res; 1999 May; 26(4):211-20. PubMed ID: 10340723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired effect of salt loading on nitric oxide-mediated relaxation in aortas from stroke-prone spontaneously hypertensive rats.
    Kagota S; Kubota Y; Nejime N; Nakamura K; Kunitomo M; Shinozuka K
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):48-54. PubMed ID: 17201735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.